Home > Insider Trading > Filing (0001209191-23-052369)

Filing Details

Accession Number:: 0001209191-23-052369
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-06 18:12:21
Reporting Period:: 2023-10-04

Accepted Time:: 2023-10-06 18:12:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601830	Recursion Pharmaceuticals Inc.	RXRX	Biological Products, (No Disgnostic Substances) (2836)	464099738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1856369	Christopher Gibson	C/O Recursion Pharmaceuticals 41 S. Rio Grande Street Salt Lake City UT 84101	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2023-10-04	31,250	$2.48	902,541	No	4	M	Direct
Class A Common Stock	Disposition	2023-10-04	59,794	$7.21	842,747	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2023-10-04	31,250	$0.00	31,250	$2.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
468,750		2030-12-30	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Option (Right to Buy)	$8.55		2033-02-01	813,600	Direct
Class A Common Stock	Stock Option (Right to Buy)	$11.40	2022-02-04	2032-02-04	5,436	Direct
Class A Common Stock	Stock Option (Right to Buy)	$11.40		2032-02-04	407,676	Direct
Class A Common Stock	Class B Common Stock	$0.00			6,511,496	Direct
Class A Common Stock	Class B Common Stock	$0.00			523,000	Indirect
Class A Common Stock	Class B Common Stock	$0.00			448,000	Indirect
Class A Common Stock	Class B Common Stock	$0.00			120,875	Indirect

Expiration Date	Remaning Holdings	Nature of Ownership
2033-02-01	813,600	Direct
2032-02-04	5,436	Direct
2032-02-04	407,676	Direct
	6,511,496	Direct
	523,000	Indirect
	448,000	Indirect
	120,875	Indirect

Footnotes

This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
This transaction was executed in multiple trades at prices ranging from $7.08 to $7.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.